Jazz Pharmaceuticals PLC - JAZZ - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Jazz Pharmaceuticals PLC - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
JAZZ	Nasdaq	2834	http://www.jazzpharmaceuticals.com/	61.22 -0.31
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Jazz Pharmaceuticals PLC The Zacks Analyst Blog Highlights: Zumiez, Mylan, AbbVie, Santarus and Jazz Pharmaceuticals - May 23rd, 2013 6:01 am Rash Of Breakouts A Bullish Sign For Foreign Stocks - May 22nd, 2013 4:01 pm Bristol-Myers, Jazz Pharmaceuticals Lead Pharma Rally - May 22nd, 2013 3:53 pm XenoPort Resumes Horizant Supply - May 22nd, 2013 2:20 pm Sanofi/REGN's Dupilumab Data Published - May 22nd, 2013 2:00 pm Swiss Issue for AMAG/Takeda's Rienso - May 22nd, 2013 1:35 pm Additional Patent for Acorda's Ampyra - May 22nd, 2013 12:55 pm Generic Launches at Mylan Continue - May 22nd, 2013 12:45 pm AbbVie Extends Galapagos Deal - May 22nd, 2013 8:40 am Jazz Reaches New 52-Week High (JAZZ) - May 22nd, 2013 8:14 am Jazz Pharmaceuticals Public Limited Company Presents at UBS Global Healthcare Conference, May-21-2013 09:30 AM - May 21st, 2013 3:10 pm Elan Provides Strategic Update - May 21st, 2013 1:46 pm FDA Accepts Actavis NDA - May 20th, 2013 9:00 am 3 Value Investing Plays in Health Care - May 16th, 2013 11:53 am Good News for Novartis' Ilaris - May 15th, 2013 3:16 pm Nektar Posts Wider Loss, Maintains View - May 15th, 2013 9:45 am Synergy Pharma Posts Wider Loss - May 15th, 2013 9:40 am Dr. Reddy's Earnings Increase Y/Y - May 15th, 2013 9:40 am 3 Stocks to Get on Your Watchlist - May 15th, 2013 8:45 am JAZZ PHARMACEUTICALS PLC Financials - May 14th, 2013 11:04 am View All Current Headlines >>